Search
Structure Therapeutics Inc
GPCRAdd to Watchlist
21.870USD
-0.070-0.32%
Close 10-30 16:00（ET）
1.56BMarket Cap
LossP/E TTM
Structure Therapeutics Inc (GPCR) Stock Price Target & Forecast
Analyst Rating
Based on 17 analysts giving stock ratings to Structure Therapeutics Inc in the past month.
Buy
6 Strong Buy
10 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
107.214USD+399.14%
GPCR Analyst Recommendation Trends
In the current month, GPCR has received 10 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. GPCR average Analyst price target in the last month is 107.214.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
6
6
6
6
6
6
6
6
10
10
10
11
11
11
10
10
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17
17
17
18
18
18
17
16
Financial Forecasting
Based on analysts' estimates, GPCR EPS is projected to reach -0.578 in FY2026Q3, following reported EPS of -0.487 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.47
-0.35
-0.40
-0.58
-0.59
Actual
0.52
-1.05
-0.49
--
--
Surprise
+211.88%
-201.93%
-22.48%
--
--
FAQs
What is Structure Therapeutics Inc's price target?
Analysts forecast that Structure Therapeutics Inc's price target is USD 65.00, with the highest forecast at USD 120.00 and the lowest forecast at USD 50.00.
How have Structure Therapeutics IncGPCR's recent earnings per share performed?
The market expectation was USD -0.49, while Structure Therapeutics IncGPCR's earnings per share (EPS) for the previous quarter was USD -1.05. EPS for the next quarter is expected at USD -0.58.
What is the analyst rating for Structure Therapeutics Inc?
Based on the ratings of Structure Therapeutics Inc's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.